Screening [hlca]    
LIVER DISEASE [dsyn]    
Non-invasive [ftcn]    
Biomarkers [clna]    
Patients [podg]    
Hyperlipidaemia, NOS [dsyn]    
Mortality [qnco]    
Related [qlco]    
Complications [patf]    
CIRRHOSIS [dsyn]    
Increasing [ftcn]    
Patients [podg]    
Patients [podg]    
MULTIPLE [qnco]    
Risk Factors [qnco]    
INSULIN RESISTANCE [patf]    
Liver Biopsy [diap]    
LARGE [qnco]    
Patients [podg]    
Patients [podg]    
Advanced [qlco]    
Fibrosis, Liver [dsyn]    
Steatohepatitis [dsyn]    
Nonalcoholic Steatohepatitis [dsyn]    
Aims [idcn]    
Non-invasive [ftcn]    
Biomarkers [clna]    
advanced disease [fndg]    
LIVER [bpoc]    
large Population [grpa]    
Patients [podg]    
Methods [inpr]    
Consecutive [qlco]    
Patients [podg]    
Lipid [orch]    
Centre [spco]    
Sera [bdsu]    
Subject [grup]    
included [ftcn]    
Patients [podg]    
Blood donors [popg]    
Advanced [qlco]    
FIBROSIS [patf]    
Identified [qlco]    
Patients [podg]    
Blood donors [popg]    
Advanced [qlco]    
Steatosis [patf]    
Patients [podg]    
Blood donors [popg]    
Highly significant [qlco]    
Linear [spco]    
Association [menp]    
METABOLIC SYNDROME [dsyn]    
LIVER DISEASE [dsyn]    
Highest [qlco]    
Type 2 [clas]    
diabetics [fndg]    
Advanced [qlco]    
Steatosis [patf]    
Advanced [qlco]    
FIBROSIS [patf]    
Conclusions [idcn]    
FIBROSIS [patf]    
Steatosis [patf]    
Patients [podg]    
APPEAR [qlco]    
Biomarkers [clna]    
Useful [qlco]    
Screening [hlca]    
Advanced [qlco]    
FIBROSIS [patf]    
Patients [podg]    
Several [qnco]    
METABOLIC SYNDROME [dsyn]    
PREVENT [phsu]    
LIVER [bpoc]    
Mortality [qnco]    
